Membrane immunoisolation of a diffusion chamber for bioartificial pancreas.

Immunoisolation is a potentially important approach to transplanting islets without any immunosuppressive therapy. The concept of immunoisolation is outlined in systems in which the transplanted tissue is separated from the immune system of the host by an artificial barrier. We previously described a diffusion chamber as a bioartificial endocrine pancreas (Bio-AEP), which was constructed by placing pancreatic endocrine cells, trapped in a mixed matrix, in the center of a ring holder sandwiched between nucleopore membranes, which were shielded by silicone. This experiment was designed to evaluate a suitable pore size for the nucleopore membrane to ensure immunoisolation during xenoimplantation of the Bio-AEP in vitro and in vivo. A nucleopore membrane of pore size 0.1 microm or 0.2 microm was employed as the semipermeable membrane which provided a mechanical barrier between the endocrine pancreas graft and the host immune system. The protective effect of the Bio-AEP from humoral immunity was determined in vitro, using sensitized sheep erythrocytes (EAs). A complement protein did not destroy the cell membranes of the EAs in the diffusion chamber containing the mixed matrix with the nucleopore membrane of 0.1 microm pore size. In an in vivo experiment, 6 streptozotocin (STZ) induced diabetic rats were implanted with Bio-AEPs constructed with nucleopore membranes of pore size 0.1 microm and containing MIN6 cells in the mixed matrix. In the STZ diabetic rats with Bio-AEPs, a return to normoglycemia was observed up to 50 weeks after implantation without the use of any immunosuppressant. Also, the body weights of the rats gradually increased. During the observation, when the Bio-AEPs were removed from the STZ diabetic rats, the blood glucose immediately returned to preimplantation levels, and the body weights of the rats also decreased. The membranes of the Bio-AEPs removed from the STZ diabetic rats showed a very thin layer of fibroblastic cells on the outer surfaces. The results indicated that the Bio-AEP, in which pancreatic endocrine cells were trapped in a mixed matrix and with a 0.1 microm pore size membrane, should be useful for xenoimplantation into diabetic animals and may open a new field in the therapy of human diabetics.

[1]  R. Taub,et al.  Amelioration of streptozotocin-induced diabetes in mice by the implantation of pancreatic islets in diffusion chambers. , 1976, The Mount Sinai journal of medicine, New York.

[2]  F. Tashiro,et al.  EMBEDDED-CULTURE OF PANCREATIC β-CELLS DERIVED FROM TRANSGENIC MOUSE INSULINOMA AS A POTENTIAL SOURCE FOR XENOTRANSPLANTATION USING A DIFFUSION CHAMBER. , 1995, Cell transplantation.

[3]  B A Solomon,et al.  Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. , 1991, Science.

[4]  J. Miyazaki,et al.  Relation between glucose-stimulated insulin secretion and intracellular calcium accumulation studied with a superfusion system of a glucose-responsive pancreatic beta-cell line MIN6. , 1993, Endocrinology.

[5]  Y. Ikada,et al.  Permeability of filters used for immunoisolation. , 1996, Tissue engineering.

[6]  Y. Omori,et al.  Development of a Method for Embedded-Culture of Pig Pancreatic Islet-Like Cell Clusters in Agarose Containing Maltose-Carrying Polystyrene (HEVM) and Nicotinamide , 1994, Cell transplantation.

[7]  G. H. Algire,et al.  Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. , 1954, Journal of the National Cancer Institute.

[8]  Cole Lb,et al.  An attack of tetanus. , 1968 .

[9]  E. Cronkite,et al.  An Improved Diffusion Chamber (DC) for Culture of Hematopoietic Cells 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  L. Vanhaelst,et al.  CORONARY-ARTERY DISEASE IN MYXŒDEMA , 1967 .

[11]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[12]  R. Gates,et al.  Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans. , 1972, Lancet.

[13]  A. Sun,et al.  The Use, in Diabetic Rats and Monkeys, of Artificial Capillary Units Containing Cultured Islets of Langerhans (Artificial Endocrine Pancreas) , 1977, Diabetes.

[14]  P. Gullino,et al.  Hormone production by cells grown in vitro on artificial capillaries. , 1974, Experimental cell research.

[15]  A. Sun,et al.  Reversal of Diabetes in BB Rats by Transplantation of Encapsulated Pancreatic Islets , 1990, Diabetes.

[16]  A. Monaco,et al.  Treatment of Severely Diabetic Pancreatectomized Dogs Using a Diffusion-Based Hybrid Pancreas , 1992, Diabetes.

[17]  G. Reach,et al.  Functional Evaluation of a Bioartificial Pancreas Using Isolated Islets Perifused with Blood Ultrafiltrate , 1981, Diabetes.

[18]  J. Miyazaki,et al.  Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. , 1990, Endocrinology.

[19]  F. Tashiro,et al.  Assessment of pore size of a semipermeable membrane for immunoisolation on xenoimplantation of pancreatic B cells using a diffusion chamber. , 1995, Transplantation proceedings.

[20]  C. Waters,et al.  Concentration profiles of platelet-sized latex beads for conditions relevant to hollow-fiber hemodialyzers. , 2008, Artificial organs.

[21]  R. Gates,et al.  REVERSAL OF STREPTOZOTOCIN-INDUCED DIABETES IN RATS BY INTRAPERITONEAL IMPLANTATION OF ENCAPSULATED NEONATAL RABBIT PANCREATIC TISSUE , 1977, The Lancet.

[22]  H. Iwata,et al.  Evaluation of Microencapsulated Islets in Agarose Gel as Bioartificial Pancreas by Studies of Hormone Secretion in Culture and by Xenotransplantation , 1989, Diabetes.

[23]  G. Wolters,et al.  Effect of Alginate-Polylysine-Alginate Microencapsulation on In Vitro Insulin Release From Rat Pancreatic Islets , 1991, Diabetes.

[24]  G. H. Algire,et al.  Recent developments in the transparent-chamber technique as adapted to the mouse. , 1949, Journal of the National Cancer Institute.